Prednisolone acetate
- Generic Name
- Prednisolone acetate
- Brand Names
- Blephamide, Econopred Plus, Flo-pred, Pred Forte, Pred Mild, Pred-G
- Drug Type
- Small Molecule
- Chemical Formula
- C23H30O6
- CAS Number
- 52-21-1
- Unique Ingredient Identifier
- 8B2807733D
- Background
Prednisolone acetate is a prednisolone molecule bound to an acetate functional group by an ester bond.
Prednisolone acetate was granted FDA approval in 1955.
- Indication
Prednisolone acetate is indicated as an anti-inflammatory or immunosuppressive agent for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, or infectious conditions. Prednisolone acetate is also indicated in organ transplant patients, as well as endocrine or neoplastic conditions.
- Associated Conditions
- Inflammation, Inflammatory Conditions, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Transplanted Organ Rejection
- Associated Therapies
- -
A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2006-06-09
- Lead Sponsor
- Novartis
- Target Recruit Count
- 30
- Registration Number
- NCT00134992
- Locations
- 🇩🇪
Kopfklinik der Ruprechts-Karls- Universität, Heidelberg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath